The insulin resistance signaling pathway would result in an imbalance between de novo lipogenesis and β-oxidation, as well as an impairment of the hepatic gluconeogenesis pathway, thereby exacerbating the fat accumulation and the resultant hepatic steatosis [45, 46]. This evidence concerns the gene INS and fatty liver disease.